Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial.

Bourhis, Jean

Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial. [electronic resource] - The Lancet. Oncology Feb 2012 - 145-53 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1474-5488

10.1016/S1470-2045(11)70346-1 doi


Adult
Aged
Carcinoma--therapy
Chemoradiotherapy--methods
Disease-Free Survival
Female
Head and Neck Neoplasms--therapy
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Neoplasm Staging
Patient Safety
Treatment Outcome